Dianthus Therapeutics (DNTH) Q3 2024 Earnings

8AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-3.78
-2.67
-1.55
-0.44

Details

Expected EPS
-0.545233
Actual EPS
-0.51
Surprise EPS
0.04
Surprise Percent
+6.46%

Description

Dianthus Therapeutics (DNTH) has reported earnings of -0.51 per share for Q3 2024.

0 Comments

Share your thoughts